| 1 | Nature Biotechnology | 3.0 | — | 23.11 | 1 | 44.50 | Nature Research |
| 2 | Nature Genetics | 3.0 | 约5.0% | 15.38 | 1 | 25.50 | Nature Research |
| 3 | Nature Cell Biology | 3.0 | 约5.0% | 9.09 | 1 | 22.70 | Nature Research |
| 4 | Nucleic Acids Research | 3.0 | 约43.75% | 8.11 | 1 | 15.00 | Oxford University Pr |
| 5 | Nature Protocols | 3.0 | 较难 | 7.40 | 1 | 18.40 | Springer Nature |
| 6 | Cell Death and Differentiation | 3.0 | 约80.0% | 5.18 | 1 | 13.60 | Springer Nature |
| 7 | Molecular Therapy | 3.0 | 较难 | 3.81 | 1 | 11.40 | Cell Press |
| 8 | Cellular and Molecular Biology Letters | 4.5 | 较易 | 2.88 | 1 | 12.20 | BioMed Central Ltd |
| 9 | Biotechnology Advances | 3.0 | 较难 | 2.76 | 1 | 14.10 | Elsevier Inc. |
| 10 | Molecular and Cellular Proteomics | 3.0 | 约66% | 2.35 | 2 | 6.30 | American Society for |
| 11 | Current Opinion in Chemical Biology | 3.0 | 较难 | 2.26 | 2 | 7.20 | Elsevier Ltd |
| 12 | Nano Today | 3.0 | — | 2.26 | 2 | 10.70 | Elsevier B.V. |
| 13 | Journal of Genetics and Genomics | 3.0 | 约75.0% | 2.17 | 1 | 7.90 | Institute of Genetic |
| 14 | Phytomedicine | 3.0 | 约25.0% | 2.09 | 1 | 11.30 | Elsevier GmbH |
| 15 | Human Mutation | 3.0 | 约50.0% | 1.97 | 3 | 1.80 | John Wiley and Sons |
| 16 | Archives of Pharmacal Research | 4.0 | 约50.0% | 1.84 | 2 | 8.20 | Pharmaceutical Socie |
| 17 | Environmental Research | 3.0 | 一般 | 1.84 | 2 | 8.20 | Academic Press Inc. |
| 18 | Critical Reviews in Biotechnology | 4.8 | 一般 | 1.78 | 2 | 8.70 | Taylor and Francis L |
| 19 | International Journal of Molecular Medicine | 3.0 | 约77.85% | 1.62 | 2 | 8.50 | Spandidos Publicatio |
| 20 | Development (Cambridge) | 3.0 | 约12.5% | 1.60 | 2 | 4.00 | Company of Biologist |
| 21 | European Journal of Cell Biology | 3.0 | 一般 | 1.43 | 2 | 4.30 | Elsevier GmbH |
| 22 | Expert Opinion on Therapeutic Targets | 3.0 | 一般 | 1.38 | 3 | 5.10 | Taylor and Francis L |
| 23 | ACS Chemical Biology | 3.3 | 较易 | 1.37 | 2 | 3.60 | American Chemical So |
| 24 | Structural Health Monitoring | 4.8 | 较易 | 1.36 | 2 | 5.70 | SAGE Publications Lt |
| 25 | Clinical Chemistry and Laboratory Medicine | 3.0 | 约62.5% | 1.29 | 3 | 4.40 | Walter de Gruyter Gm |
| 26 | FASEB Journal | 3.0 | 约25.0% | 1.25 | 2 | 4.30 | John Wiley & Son |
| 27 | Stem Cells | 3.0 | 约31.25% | 1.24 | 3 | 4.80 | Oxford University Pr |
| 28 | Stem Cell Reviews and Reports | 3.0 | 一般 | 1.22 | 3 | 4.90 | Springer |
| 29 | Journal of Proteome Research | 3.0 | 较难 | 1.19 | 2 | 3.80 | American Chemical So |
| 30 | Vaccine | 4.5 | 约50.0% | 1.19 | 3 | 3.40 | Elsevier Ltd |
| 31 | Journal of Zhejiang University: Science B | 3.0 | — | 1.18 | 2 | 5.70 | Zhejiang University |
| 32 | Proteomics | 3.0 | 较难 | 1.12 | 3 | 4.10 | Wiley-VCH Verlag |
| 33 | Proteins: Structure, Function and Genetics | 3.0 | 较易 | 1.10 | 3 | 3.30 | — |
| 34 | Journal of Hypertension | 3.0 | 约50.0% | 1.07 | 3 | 5.60 | Lippincott Williams |
| 35 | Plasmid | 3.0 | — | 1.06 | 3 | 2.30 | Academic Press Inc. |
| 36 | Acta Biochimica et Biophysica Sinica | 3.0 | 约95.0% | 1.00 | 2 | 4.50 | Science Press |
| 37 | Biochimie | 3.0 | 较易 | 0.98 | 3 | 3.40 | Elsevier B.V. |
| 38 | Journal of Applied Crystallography | 4.7 | 较难 | 0.97 | 3 | 2.70 | International Union |
| 39 | Colloids and Surfaces B: Biointerfaces | 3.3 | 较易 | 0.95 | 2 | 5.90 | Elsevier B.V. |
| 40 | DNA Research | 4.5 | 约15.0% | 0.95 | 2 | 2.80 | Oxford University Pr |
| 41 | Metabolomics | 3.0 | 约50.0% | 0.94 | 3 | 3.50 | Springer |
| 42 | Clinica Chimica Acta | 3.0 | 约50.0% | 0.94 | 3 | 4.10 | Elsevier B.V. |
| 43 | Analytica Chimica Acta | 3.1 | 约73% | 0.93 | 1 | 6.10 | Elsevier B.V. |
| 44 | Research in Microbiology | 3.0 | 较易 | 0.92 | 3 | 4.40 | Elsevier Masson s.r. |
| 45 | Frontiers in Bioscience - Landmark | 3.0 | 约46.25% | 0.92 | 3 | 4.10 | IMR Press Limited |
| 46 | World Journal of Microbiology and Biotechnology | 3.0 | 约70.0% | 0.91 | 2 | 4.70 | Springer Science and |
| 47 | Brain Research | 3.0 | 约77.5% | 0.89 | 3 | 3.20 | Elsevier B.V. |
| 48 | Oncology Reports | 3.0 | 约54.23% | 0.89 | 3 | 4.70 | Spandidos Publicatio |
| 49 | Engineering in Life Sciences | 3.0 | 约80.0% | 0.88 | 3 | 4.10 | Wiley-VCH Verlag |
| 50 | Journal of Industrial Microbiology and Biotechnology | 3.0 | 约75.0% | 0.87 | 3 | 4.50 | Oxford University Pr |
| 51 | Pharmaceutical Research | 3.0 | 较易 | 0.87 | 3 | 4.10 | Springer |
| 52 | European Journal of Pharmaceutics and Biopharmaceutics | 3.0 | 约80% | 0.85 | 3 | 5.00 | Elsevier B.V. |
| 53 | Glycobiology | 3.0 | 较易 | 0.84 | 2 | 3.30 | Oxford University Pr |
| 54 | Macromolecular Bioscience | 3.0 | 较难 | 0.81 | 3 | 4.20 | Wiley-VCH Verlag |
| 55 | Journal of Materials Science: Materials in Medicine | 3.6 | 约72.5% | 0.77 | 3 | 4.70 | Springer |
| 56 | Journal of Biotechnology | 4.2 | 约35.0% | 0.77 | 2 | 4.00 | Elsevier B.V. |
| 57 | Functional and Integrative Genomics | 3.0 | 约50.0% | 0.75 | 3 | 4.00 | — |
| 58 | Nuclear Medicine and Biology | 3.0 | 一般 | 0.75 | 4 | 3.10 | Elsevier Inc. |
| 59 | Biochimica et Biophysica Acta - Biomembranes | 3.0 | 较难 | 0.74 | 3 | 2.40 | Elsevier B.V. |
| 60 | Molecular Imaging and Biology | 3.0 | 一般 | 0.74 | 3 | 2.50 | Springer Science and |
| 61 | Process Biochemistry | 3.0 | 约55% | 0.74 | 2 | 4.40 | Elsevier Ltd |
| 62 | Journal of Photochemistry and Photobiology B: Biology | 4.5 | 较易 | 0.74 | 2 | 4.00 | Elsevier B.V. |
| 63 | Physical Biology | 3.0 | 较易 | 0.73 | 4 | 1.50 | IOP Publishing Ltd. |
| 64 | Nutrition and Cancer | 3.0 | — | 0.71 | 3 | 2.70 | Taylor and Francis L |
| 65 | Tissue Engineering - Part A | 3.0 | — | 0.70 | 3 | 2.80 | Mary Ann Liebert Inc |
| 66 | Free Radical Research | 3.0 | 较易 | 0.69 | 3 | 3.10 | Taylor and Francis L |
| 67 | Ultrasound in Medicine and Biology | 3.0 | 较易 | 0.69 | 3 | 2.80 | Elsevier Inc. |
| 68 | Clinical Biochemistry | 3.0 | — | 0.69 | 3 | 2.30 | Elsevier Inc. |
| 69 | Journal of Proteomics | 3.0 | 约43.75% | 0.69 | 3 | 3.10 | Elsevier B.V. |
| 70 | Fungal Genetics and Biology | 3.0 | 约41.66% | 0.67 | 3 | 3.00 | Academic Press Inc. |
| 71 | Chemical Biology and Drug Design | 5.0 | 约75.0% | 0.67 | 4 | 3.30 | John Wiley and Sons |
| 72 | Archives of Microbiology | 3.0 | 较易 | 0.66 | 3 | 3.40 | Springer Science and |
| 73 | Bioinspiration and Biomimetics | 3.0 | 较易 | 0.64 | 3 | 3.50 | IOP Publishing Ltd. |
| 74 | Recent Patents on Anti-Cancer Drug Discovery | 3.0 | 较易 | 0.64 | 3 | 2.40 | Bentham Science Publ |
| 75 | Rejuvenation Research | 3.0 | 约25.0% | 0.63 | 3 | 1.80 | Mary Ann Liebert Inc |
| 76 | Physiological Measurement | 3.0 | 约50% | 0.63 | 3 | 2.50 | IOP Publishing Ltd. |
| 77 | Yeast | 3.0 | 较易 | 0.63 | 3 | 2.20 | John Wiley and Sons |
| 78 | Molecular Diversity | 3.8 | 较易 | 0.61 | 2 | 4.30 | Springer Nature |
| 79 | Annals of Human Genetics | 3.0 | 约50.0% | 0.60 | 4 | 1.50 | Wiley-Blackwell Publ |
| 80 | Molecular Informatics | 3.0 | 较易 | 0.59 | 3 | 3.10 | John Wiley and Sons |
| 81 | Biomarkers | 3.0 | 约75.0% | 0.59 | 4 | 2.20 | Taylor and Francis L |
| 82 | Cancer Biomarkers | 3.0 | 约50.0% | 0.57 | 4 | 1.80 | SAGE Publications Lt |
| 83 | Biotechnology Progress | 4.5 | 约23.75% | 0.56 | 3 | 2.80 | Wiley-Blackwell |
| 84 | Micron | 3.0 | 约50.0% | 0.56 | 3 | 2.70 | Elsevier Ltd |
| 85 | Journal of Luminescence | 4.4 | 约62.5% | 0.56 | 3 | 3.80 | Elsevier B.V. |
| 86 | Cellular Reprogramming | 3.0 | 约75.0% | 0.55 | 4 | 2.70 | Mary Ann Liebert Inc |
| 87 | Journal of Cluster Science | 3.0 | — | 0.55 | 3 | 4.10 | Springer New York |
| 88 | Proteome Science | 4.5 | 较易 | 0.55 | 3 | — | BioMed Central Ltd |
| 89 | Electronic Journal of Biotechnology | 3.0 | 约95.0% | 0.54 | 3 | 3.20 | Pontificia Universid |
| 90 | Virus Genes | 3.0 | — | 0.54 | 4 | 2.00 | Springer |
| 91 | Journal of Biomolecular Structure and Dynamics | 3.0 | 约25.0% | 0.53 | 3 | 2.50 | Taylor and Francis L |
| 92 | Stem Cells and Development | 3.0 | 约50.0% | 0.53 | 4 | 1.90 | Mary Ann Liebert Inc |
| 93 | Experimental and Clinical Endocrinology and Diabetes | 3.0 | 约50.0% | 0.53 | 4 | 1.80 | Georg Thieme Verlag |
| 94 | Journal of Biological Inorganic Chemistry | 3.0 | 一般 | 0.53 | 3 | 2.80 | Springer Science and |
| 95 | Journal of Microbiological Methods | 3.0 | 约62.5% | 0.52 | 4 | 2.50 | Elsevier B.V. |
| 96 | In Vitro Cellular and Developmental Biology - Animal | 3.0 | 约26.25% | 0.52 | 4 | 2.00 | Springer |
| 97 | International Journal for Numerical Methods in Biomedical Engineering | 3.0 | — | 0.52 | 3 | 2.10 | Wiley-Blackwell |
| 98 | Anti-Cancer Drugs | 3.0 | — | 0.51 | 4 | 2.00 | Lippincott Williams |
| 99 | BioTechniques | 3.3 | 约50.0% | 0.50 | 4 | 2.60 | — |
| 100 | Pharmacogenetics and Genomics | 3.0 | 约5.0% | 0.50 | 4 | 1.60 | Lippincott Williams |
| 101 | Asian Pacific Journal of Cancer Prevention | 3.0 | — | 0.50 | — | — | Asian Pacific Organi |
| 102 | Antonie van Leeuwenhoek, International Journal of General and Molecular Microbiology | 3.0 | — | 0.49 | 4 | 2.00 | Springer Science and |
| 103 | Medical Engineering and Physics | 3.0 | — | 0.49 | 3 | 2.40 | Elsevier Ltd |
| 104 | Genetics and Molecular Biology | 3.0 | 约5.0% | 0.49 | 4 | 1.70 | Brazilian Society of |
| 105 | Carbohydrate Research | 3.0 | 约62.5% | 0.48 | 3 | 3.40 | Elsevier Ltd |
| 106 | Folia Biologica (Czech Republic) | 3.0 | — | 0.48 | 4 | 1.80 | Charles University i |
| 107 | Biopolymers | 3.0 | — | 0.44 | 3 | 2.90 | John Wiley and Sons |
| 108 | Current Pharmaceutical Analysis | 3.0 | 约50.0% | 0.44 | 4 | 3.60 | KeAi Communications |
| 109 | European Physical Journal E | 3.0 | 约50.0% | 0.41 | 3 | 2.60 | Springer New York |
| 110 | Chemical Papers | 3.0 | 约88% | 0.41 | 3 | 2.70 | Springer Internation |
| 111 | Psychiatric Genetics | 3.0 | 较易 | 0.40 | 4 | 1.40 | Lippincott Williams |
| 112 | Luminescence | 3.0 | 约75.0% | 0.40 | 3 | 2.80 | John Wiley and Sons |
| 113 | Journal of Fluorine Chemistry | 3.0 | — | 0.35 | 3 | 1.60 | Elsevier B.V. |
| 114 | Current Nanoscience | 3.0 | — | 0.34 | 4 | 1.90 | Bentham Science Publ |
| 115 | Molecular Biology | 3.0 | — | 0.34 | 4 | 1.30 | — |
| 116 | Journal of Electrostatics | 3.0 | 约75% | 0.33 | 3 | 2.30 | Elsevier B.V. |
| 117 | Hemoglobin | 3.0 | — | 0.31 | 4 | 1.00 | Taylor and Francis L |
| 118 | International Journal of Chemical Kinetics | 3.0 | 约50% | 0.31 | 3 | 1.70 | John Wiley & Son |
| 119 | Letters in Drug Design and Discovery | 3.0 | — | 0.30 | 4 | 1.60 | KeAi Communications |
| 120 | Biocatalysis and Biotransformation | 3.0 | 约50% | 0.29 | 4 | 1.50 | Taylor and Francis L |
| 121 | Polish Journal of Chemical Technology | 4.5 | 约75.0% | 0.27 | 4 | 1.40 | De Gruyter Open Ltd |
| 122 | Clinical Laboratory | 3.0 | 约85.0% | 0.26 | 4 | 0.70 | Verlag Klinisches La |
| 123 | Russian Journal of Bioorganic Chemistry | 3.0 | — | 0.26 | 3 | 1.70 | — |
| 124 | Biomedical Engineering - Applications, Basis and Communications | 4.0 | — | 0.23 | 4 | 1.00 | World Scientific |
| 125 | Journal of Liquid Chromatography and Related Technologies | 3.3 | 约43.33% | 0.22 | 3 | 1.10 | Taylor and Francis L |
| 126 | Indian Journal of Biochemistry and Biophysics | 3.0 | — | 0.22 | 4 | — | National Institute o |
| 127 | Phosphorus, Sulfur and Silicon and the Related Elements | 3.0 | — | 0.21 | 4 | 1.30 | Taylor and Francis L |
| 128 | Scientia Sinica Chimica | 3.0 | — | 0.19 | — | — | Science Press |
| 129 | Genetics and Molecular Research | 3.0 | — | 0.13 | 4 | — | Fundacao de Pesquisa |
| 130 | Progress in Biochemistry and Biophysics | 3.1 | 约40.0% | 0.13 | 3 | 0.30 | Science Press |
| 131 | Cancer Research on Prevention and Treatment | 3.0 | — | 0.12 | — | — | CHINA RESEARCH ON PR |
| 132 | Chinese Journal of Biologicals | 3.0 | — | 0.10 | — | — | Changchun Institute |